Nello Mainolfi, Chief Executive Officer at Kymera Therapeutics, Inc. (KYMR), sold 30,000 shares at $89.78 ($2.7M) on 2026-02-25, disclosed to the SEC on 2026-02-25.
Open-market sale of $2.7M KYMR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.78 | 19,764 | $1.8M | 65.5% |
| 2 | $90.39 | 5,434 | $491K | 18.1% |
| 3 | $91.76 | 3,293 | $302K | 11.2% |
| 4 | $92.81 | 1,501 | $139K | 5.1% |
| 5 | $93.49 | 8 | $748 | 0.0% |
| Total | $90.26 avg | 30,000 |
| $2.7M |
| 100% |
| Filing → |
| KYMR | SELL | 2026-07-02 | $9.2M | — | Filing → |
| KYMR | SELL | 2026-04-29 | $2.4M | — | Filing → |
| KYMR | SELL | 2025-12-31 | $4.7M | — | Filing → |